As TBXT is becoming an attractive target for molecular targeted therapy in chordoma, a simple and reliable T‐ARMS‐PCR offers an effective screening method for rs2305089 in these patients and might pave the way for new molecular targeted therapy techniques. This evidence concerns the gene TBXT and chordoma.